Advertisement

Advertisement

IMNN Stock Latest News

Imunon: Buy Rating Reiterated as Phase 3 IMNN-001 Progress and Extended Cash Runway Support Unchanged $10 Price Target

RatingsImunon: Buy Rating Reiterated as Phase 3 IMNN-001 Progress and Extended Cash Runway Support Unchanged $10 Price Target

Imunon Adopts New Equity-Based Executive Compensation Program

PremiumCompany Announcements

Imunon Adopts New Equity-Based Executive Compensation Program

5d ago

Imunon reports Q2 EPS (54c), consensus (50c)

PremiumThe Fly

Imunon reports Q2 EPS (54c), consensus (50c)

6d ago

Imunon provides update on OVATION 3 trial of IMNN-001

PremiumThe Fly

Imunon provides update on OVATION 3 trial of IMNN-001

18d ago

Imunon announces new preliminary data from IMNN-001 trial

PremiumThe Fly

Imunon announces new preliminary data from IMNN-001 trial

27d ago

Imunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed

PremiumThe FlyImunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed

2M ago

Imunon Names Josh Blacher Interim Chief Financial Officer

Company Announcements

Imunon Names Josh Blacher Interim Chief Financial Officer

2M ago

Imunon announces IDMC recommendation for continuation of OVATION 3 trial

The Fly

Imunon announces IDMC recommendation for continuation of OVATION 3 trial

2M ago

Imunon Shareholders Expand Stock Incentive Plan, Back Governance

PremiumCompany Announcements

Imunon Shareholders Expand Stock Incentive Plan, Back Governance

2M ago

Imunon Secures $10 Million Non-Dilutive Structured Financing

PremiumCompany Announcements

Imunon Secures $10 Million Non-Dilutive Structured Financing

2M ago

Imunon Earnings Call Balances Breakthroughs and Cash Strain

PremiumCompany Announcements

Imunon Earnings Call Balances Breakthroughs and Cash Strain

3M ago

Imunon’s Earnings Call Balances Survival Gains and Risks

PremiumCompany Announcements

Imunon’s Earnings Call Balances Survival Gains and Risks

3M ago

Imunon reports Q1 EPS (84c), consensus ($1.28)

PremiumThe FlyImunon reports Q1 EPS (84c), consensus ($1.28)

3M ago

Imunon Adopts Change-of-Control Severance Agreements for Executives

Company Announcements

Imunon Adopts Change-of-Control Severance Agreements for Executives

3M ago

Imunon initiated with a Buy at Maxim

The Fly

Imunon initiated with a Buy at Maxim

4M ago

Imunon Earnings Call: Strong Data, Tight Cash Runway

PremiumCompany Announcements

Imunon Earnings Call: Strong Data, Tight Cash Runway

5M ago

Imunon announces final clinical data from OVATION 2 clinical trial

PremiumThe Fly

Imunon announces final clinical data from OVATION 2 clinical trial

5M ago

IMNN Earnings this Week: How Will it Perform?

PremiumPre-Earnings

IMNN Earnings this Week: How Will it Perform?

5M ago

Imunon Expands At-The-Market Equity Offering Capacity

PremiumCompany Announcements

Imunon Expands At-The-Market Equity Offering Capacity

5M ago

Imunon announces orderly retirement of chief scientific officer

PremiumCompany AnnouncementsImunon announces orderly retirement of chief scientific officer

6M ago

Imunon announces reorganization to eliminate headcount for Phase 3 trial

The Fly

Imunon announces reorganization to eliminate headcount for Phase 3 trial

6M ago

Imunon Announces CFO Transition and Reappointment of Jeffrey Church

Company Announcements

Imunon Announces CFO Transition and Reappointment of Jeffrey Church

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >